Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.10
Delayed Data
As of Feb 05
 -0.25 / -3.94%
Today’s Change
3.93
Today|||52-Week Range
8.48
-22.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues25.0M23.0M24.4M25.1M
 
 
 
 
 
Cost of Goods Sold12.1M11.9M11.9M12.2M
 
 
 
 
 
Depreciation And Amortization1.5M1.7M1.8M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income11.4M9.5M10.7M11.1M
 
 
 
 
 
General Expenses10.1M10.0M10.7M11.0M
 
 
 
 
 
Research And Development319.0K613.0K743.0K815.0K
 
 
 
 
 
Total Operating Expenses23.7M23.6M24.3M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3M-561.0K28.0K114.0K
 
 
 
 
 
Interest Expense On Debt193.0K195.0K189.0K239.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.1M-756.0K-161.0K-125.0K
 
 
 
 
 
Income Taxes-79.0K-5.0K-15.0K0.00
 
 
 
 
Net Income1.0M-761.0K-176.0K-125.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.0M60.3M60.4M60.5M
 
 
 
 
 
Shares To Calculate EPS Diluted62.7M60.3M60.4M60.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.01$0.00$0.00
 
 
 
EPS Diluted$0.02-$0.01-$0.00-$0.00